ADO Charting and Technical Analysis, page-4503

Ok Mattoe, so you're continually making this point that Covid is over and there is no point in testing for it anymore. It's no worse than the common cold. But what are you implying in regards to Anteo? What is the point you are trying to make? Are you actually implying Anteo should cease all development on the Eugeni platform? Is there no value in a highly accurate POC system?

Because this has been spelt out by the company for the past 2 years. This is a platform that will have a pipeline (there you go Lev) of tests. This is simple diversification within the diagnostics industry. And for those that don't understand why Anteotech is developing a diagnostics platform, and why they can't just focus on battery tech, well, once upon a time this company was AnteoDiagnostics. Some would do well to understand the history here and where the majority of R&D in this company's surface chemistry has been derived. I for one haven't been invested in this company for nearly a decade just to see it continually pivot.

POC diagnostics is still a huge opportunity, and one that Anteo can totally capitalise on. Give this new management a chance.